Gonda, X http://orcid.org/0000-0001-9015-4203
Eszlari, N http://orcid.org/0000-0003-4913-028X
Kovacs, D
Anderson, I M
Deakin, J F W
Juhasz, G
Bagdy, G
Article History
Received: 2 November 2015
Revised: 16 February 2016
Accepted: 5 March 2016
First Online: 3 May 2016
Competing interests
: JFWD variously performed consultancy, speaking engagements and research for Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Schering Plough, Janssen-Cilag and Servier (all fees are paid to the University of Manchester to reimburse them for the time taken); he also has share options in P1vital. IMA received consultancy fees from Alkermes, Lundbeck-Otsuka Ltd, Janssen-Cilag Ltd. The remaining authors declare no conflict of interest.